Effect of body mass index on outcome in pediatric heart transplant patients

Joseph W Rossano1, Michelle A Grenier, William J Dreyer

  • 1Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA. jrossano@bcm.tmc.edu

Insights

Being underweight at the time of pediatric heart transplant is linked to poorer graft survival. Weight gain after transplant is common, and being overweight does not negatively impact survival.

Area of Science:

  • Pediatric Cardiology
  • Transplant Surgery
  • Immunology

Background:

  • Obesity and cachexia are known risk factors for adverse outcomes in adult transplant recipients.
  • Limited data exists on the impact of body mass index (BMI) on outcomes in pediatric heart transplant patients.

Purpose of the Study:

  • To investigate the association between body mass index (BMI) and long-term outcomes in pediatric heart transplant recipients.
  • To determine if pre-transplant BMI influences graft survival in children.

Main Methods:

  • Retrospective analysis of pediatric heart transplant patients (age > 2 years) from 1985 to 2004.
  • Assessment of body mass index (BMI) at transplant and 1 year post-transplant.
  • Evaluation of long-term graft survival based on weight groups.

Main Results:

  • Underweight patients (< 5th percentile BMI) at transplant had significantly decreased graft survival (mean 6.7 years) compared to normal weight patients (mean 10.6 years).
  • Overweight patients (> or = 95th percentile BMI) at transplant did not show decreased graft survival.
  • Being underweight at transplant was identified as an independent predictor of reduced graft survival on multivariate analysis.

Conclusions:

  • Weight gain is common post-transplant in pediatric heart recipients, with only 4% remaining underweight at 1 year.
  • Graft survival in overweight pediatric heart transplant recipients was comparable to normal-weight patients.
  • Pre-transplant underweight status is a significant independent risk factor for decreased graft survival in pediatric heart transplantation.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...